Clinical Trial Update: Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating neoadjuvant immunochemotherapy for locally advanced Esophagogastric Junction adenocarcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagogastric Junction Adenocarcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Esophagogastric Junction Adenocarcinoma | Phase 2 | Status: RECRUITING